Food and Drug Administration, HHS.
Final rule; technical amendment; correction.
The Food and Drug Administration (FDA) is correcting a document that amended its regulations to reflect name and address changes for the Office of Compliance, Center for Drug Evaluation and Research (CDER). The document was published in the Federal Register of August 11, 2004 (69 FR 48774), with incorrect information regarding the mail codes for the Office of Compliance, CDER. This action is editorial in nature and is intended to provide accuracy and clarity to the agency's regulations.
This rule is effective August 11, 2004. Start Further Info
FOR FURTHER INFORMATION CONTACT:
Joyce A Strong, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.End Further Info End Preamble Start Supplemental Information
FDA is correcting a document that amended its regulations in 21 CFR part 5 to correct certain mail codes in the Office of Compliance, CDER.Start List of Subjects
List of Subjects in 21 CFR Part 5End List of Subjects
Authority delegations (Government agencies), Imports, Organization and functions (Government agencies).Start Amendment Part
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs,End Amendment Part
PART 5—ORGANIZATIONStart Amendment Part
1. The authority citation forEnd Amendment Part Start Amendment Part
2. Section 5.1100 is amended under the heading “CENTER FOR DRUG EVALUATION AND RESEARCH.End Amendment Part
CENTER FOR DRUG EVALUATION AND RESEARCH.1
Office of Compliance.1
Division of New Drugs and Labeling Compliance (HFD-310).
Division of Manufacturing and Product Quality (HFD-320).
Division of Compliance Risk Management and Surveillance (HFD-330).Start Signature
Dated: August 20, 2004.
Assistant Commissioner for Policy.
[FR Doc. 04-19598 Filed 8-26-04; 8:45 am]
BILLING CODE 4160-01-S